Medifast, Inc. (MED)
12.64
+0.01
(+0.08%)
USD |
NYSE |
May 22, 14:54
Medifast Research and Development Expense (Quarterly) : 1.10M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Kenvue, Inc. | 84.00M |
| Skinhealth Systems, Inc. | 1.102M |
| Waldencast Plc | -- |
| The Clorox Co. | 27.00M |
| USANA Health Sciences, Inc. | -- |